Captor Capital Corp. (CPTR.CN)

0.5700 -0.0100 (-1.72%) At close: 2:27PM EST

Captor Capital Corp.

4 King Street West
Suite 401
Toronto, ON M5H 1B6
Canada
416 504 3978
http://captorcapital.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. John Zorbas	CEO, Pres & Director	220k	N/A	1971
Mr. Jing Peng CPA, CA, MMPA	Chief Financial Officer	18k	N/A	1977
Mr. Oliver Summers	Pres of Retail Dispensaries	223.16k	N/A	N/A
Mr. Adam Wilks	Chief Exec. Officer of JV Subsidiary for California Operations	N/A	N/A	1986

Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Captor Capital Corp. engages in the manufacture and retail sale of cannabis products in the United States. It operates two dispensaries under the CHAI Cannabis Co. brand in Santa Cruz and Monterey, California, as well as operates an e-commerce site under the CHAI-brand. The company was formerly known as NWT Uranium Corp. and changed its name to Captor Capital Corp. in June 2017. Captor Capital Corp. was incorporated in 2003 and is based in Toronto, Canada.

Corporate Governance

Captor Capital Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.